{
    "2021-08-27": [
        [
            {
                "time": "",
                "original_text": "西部证券维持同仁堂买入评级，2021年中报点评：收入业绩增长符合预期，药品与商业发展稳健",
                "features": {
                    "keywords": [
                        "西部证券",
                        "同仁堂",
                        "买入评级",
                        "2021年中报",
                        "收入业绩增长",
                        "药品",
                        "商业发展"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "商业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}